AMI ORGANICS
|
|
BOM : 543349     NSE : AMIORG     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : NA |
Feb 06,2023 |
Price(EOD): ₹ 891.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 3,246.15 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
AMI ORGANICS | -0.1% | -6% | -14.7% |
SUN PHARMACEUTICAL INDUSTRIES | -1.1% | 0.8% | 15.6% |
DIVIS LABORATORIES | -16.3% | -19.7% | -31.6% |
CIPLA | 1.3% | -5.4% | 7.5% |
DR REDDYS LABORATORIES | 0.6% | 1.3% | -1.3% |
TORRENT PHARMACEUTICALS | 1.2% | -1.3% | 12% |
ABBOTT INDIA | 0.2% | -5.5% | 28.7% |
ZYDUS LIFESCIENCES | 9.2% | 8.7% | 4.7% |
ALKEM LABORATORIES | 2% | 0.9% | -14% |
FUNDAMENTAL ANALYSIS OF AMI ORGANICS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AMI ORGANICS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
41.95
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 77.46 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 6.22
P/B Calculated based on Book Value of Rs 522.27 Cr
[Latest Year - Mar2022 - Consolidated Results ] 5.66
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 573.90 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
842% 846% -38% |
SHARE PRICE MOMENTUM OF AMI ORGANICS
AMI ORGANICS vs SENSEX
DEBT OF AMI ORGANICS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0 0.83 0.55 0.46 |
0 0.85 0.53 0.46 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF AMI ORGANICS
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF AMI ORGANICS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
3.65% 9.49% 15% 17.05% |
7.94% 2.9% 3.54% 14.44% |
QtrlyTrend |
8 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
AMI ORGANICS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 1.5% | -3.4% | -5.1% |
S&P BSE MIDSMALLCAP | 1.5% | -3% | -3.2% |
S&P BSE ALLCAP | 0.5% | -3.1% | -1.2% |
S&P BSE HEALTHCARE | -1.6% | -3.6% | -9.4% |
You may also like the below Video Courses
FAQ about AMI ORGANICS
Is AMI ORGANICS good for long term investment?
As on Feb 06,2023, the Fundamentals of AMI ORGANICS look Strong and hence it may be good for long term investment! See Financial Performance of AMI ORGANICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AMI ORGANICS UnderValued or OverValued?
As on Feb 06,2023, AMI ORGANICS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AMI ORGANICS ?
As on Feb 06,2023, the Intrinsic Value of AMI ORGANICS is Rs. 94.72 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 94.72
Fair Value [Median EV / Sales Model] : Rs. 94.26
Fair Value [Median Price / Sales Model] : Rs. 1,448.78
Estimated Median Fair Value of AMI ORGANICS : Rs. 94.72
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is AMI ORGANICS trading at a Premium or Discount?
As on Feb 06,2023, AMI ORGANICS is trading at a Premium of 842% based on the estimates of Median Intrinsic Value!